Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| de Kleijn S et al. | 2011 | intact cell/cell culture, human peripheral blood mononuclear cells | magnetic field, static magnetic field, low frequency | 3–5 µT |
| Ledda M et al. | 2013 | intact cell/cell culture, NT2 (human pluripotent embryonal carcinoma cells) | magnetic field, static magnetic field, low frequency | 2.5–10 µT |
| Ashta A et al. | 2020 | intact cell/cell culture, A172 (human glioblastoma cells) | magnetic field, static magnetic field, low frequency, co-exposure, also other exposures without EMF | - |
| De Carlo F et al. | 2012 | intact cell/cell culture, C2C12 cells (undifferentiated mouse myoblasts) | magnetic field, static magnetic field, low frequency, co-exposure, therapeutic/medical device | 18 µT |
| Vinhas A et al. | 2024 | intact cell/cell culture, human tendon cells (hTDCs) | magnetic field, static magnetic field, signals/pulses | - |
| Anton-Leberre V et al. | 2010 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | magnetic field, static magnetic field, signals/pulses, DC | 14–55 T |
| Hiraoka M et al. | 1992 | intact cell/cell culture, HeLa S3 (human cervical carcinoma cell line) | static magnetic field | 0.18–0.2 T |
| Cohly HH et al. | 2003 | intact cell/cell culture, ATCC-CRL-1427 (MG-63 human osteosarcoma cell) | static magnetic field | 3.2 mT |
| Hirai T et al. | 2004 | intact cell/cell culture | static magnetic field | 100 mT |
| Horiuchi S et al. | 2001 | bacterium, <i>Escherichia coli</i>/B | static magnetic field | 5.2 T |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
